Business Context and Reporting Period
Company: AudioEye, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 23, 2013
Reporting Period: Events occurring between June 17, 2013, and December 23, 2013.
The filing discloses two separate private placements of unregistered equity securities (common stock and warrants) to accredited investors. The securities were issued in reliance on Section 4(2) of the Securities Act of 1933 and Regulation D.
Key Financial Metrics and Capital Raised
| Placement | Period | Units Sold | Common Shares | Warrants Issued | Gross Proceeds | Placement Agent Fees |
|---|---|---|---|---|---|---|
| First Private Placement | June 17 – Nov 13, 2013 | 1,142,000 | 1,142,000 | 1,221,360 | $571,000 | $39,680 |
| Second Private Placement | Dec 23, 2013 | 10,835,002 | 10,835,002 | 11,701,806 | $3,250,500.40 | $226,200.01 |
| Total | Combined | 11,977,002 | 11,977,002 | 12,923,166 | $3,821,500.40 | $265,880.01 |
Warrant Terms:
- First Placement: 3-year term (4 years for agent), exercise price $0.50/share.
- Second Placement: 5-year term, exercise price $0.40/share.
Use of Proceeds: General corporate purposes.
Other Metrics: The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The primary material change is the significant increase in outstanding equity and potential dilution resulting from the Second Private Placement, which raised approximately $3.25 million compared to $571,000 in the First Private Placement. The Second Placement involved the sale of over 10.8 million units, substantially larger than the 1.14 million units sold in the earlier period.
Outlook, Risks, and Contingencies
- Registration Rights: The Company has agreed to register the shares issued and shares issuable upon exercise of the warrants pursuant to registration rights agreements. The securities are currently restricted and cannot be offered or sold in the U.S. without an effective registration statement or exemption.
- Dilution Risk: The issuance of warrants to purchase approximately 12.9 million additional shares represents a significant potential dilution to existing shareholders.
- Management Commentary: No specific forward-looking guidance or operational outlook was provided in this filing beyond the stated intent to use proceeds for general corporate purposes.
Investor Verification Checklist
- Verify the total number of authorized shares and the current share count to assess the percentage dilution from the 11.9 million new shares and 12.9 million warrant shares.
- Confirm the status of the registration rights agreements and the timeline for the Company to file a registration statement for the new securities.
- Review the Company's most recent 10-K or 10-Q to determine current cash reserves and whether the $3.8 million in proceeds is sufficient to meet operational needs.
- Check for any subsequent filings regarding the exercise of warrants or additional capital raises.